Clarifying the Role of Incretin-Based Therapies in the Treatment of Type 2 Diabetes MellitusCAMPBELL, R. Keith.Clinical therapeutics. 2011, Vol 33, Num 5, pp 511-527, issn 0149-2918, 17 p.Article

Rationale for dipeptidyl peptidase 4 inhibitors : A new class of oral agents for the treatment of type 2 diabetes mellitusCAMPBELL, R. Keith.The Annals of pharmacotherapy. 2007, Vol 41, Num 1, pp 51-60, issn 1060-0280, 10 p.Article

Insulin in the treatment of type 2 diabetes mellitusWHITE, John R; CAMPBELL, R. Keith.American journal of health-system pharmacy. 2003, Vol 60, Num 11, pp 1145-1152, issn 1079-2082, 8 p.Article

Liraglutide: A Once-Daily Incretin Mimetic for the Treatment of Type 2 Diabetes MellitusNEUMILLER, Joshua J; CAMPBELL, R. Keith.The Annals of pharmacotherapy. 2009, Vol 43, Num 9, pp 1433-1444, issn 1060-0280, 12 p.Article

Dipeptidyl Peptidase-4 Inhibitors for the Treatment of Type 2 Diabetes MellitusNEUMILLER, Joshua J; WOOD, Lindy; CAMPBELL, R. Keith et al.Pharmacotherapy. 2010, Vol 30, Num 5, pp 463-484, issn 0277-0008, 22 p.Article

Biochemical pathways for microvascular complications of diabetes mellitusSETTER, Stephen M; CAMPBELL, R. Keith; CAHOON, Clifton J et al.The Annals of pharmacotherapy. 2003, Vol 37, Num 12, pp 1858-1866, issn 1060-0280, 9 p.Article

A Review of Inhaled Technosphere InsulinNEUMILLER, Joshua J; CAMPBELL, R. Keith; WOOD, Lindy D et al.The Annals of pharmacotherapy. 2010, Vol 44, Num 7-8, pp 1231-1239, issn 1060-0280, 9 p.Article

Inhaled dry powder insulin for the treatment of diabetes mellitusSETTER, Stephen M; LEVIEN, Terri L; ILTZ, Jason L et al.Clinical therapeutics. 2007, Vol 29, Num 5, pp 795-813, issn 0149-2918, 19 p.Article

Nateglinide therapy for type 2 Diabetes mellitusLEVIEN, Terri L; BAKER, Danial E; CAMPBELL, R. Keith et al.The Annals of pharmacotherapy. 2001, Vol 35, Num 11, pp 1426-1434, issn 1060-0280Article

Dangerous and common drug interactions in patients with diabetes mellitusWHITE, John R; CAMPBELL, R. Keith.Endocrinology and metabolism clinics of North America. 2000, Vol 29, Num 4, issn 0889-8529, vii,789-802 [15 p.]Article

Metformin hydrochloride in thetreatment of type 2 diabetes mellitus: A clinical review with a focus on dual therapySETTER, Stephen M; ILTZ, Jason L; THAMS, Jason et al.Clinical therapeutics. 2003, Vol 25, Num 12, pp 2991-3026, issn 0149-2918, 36 p.Article

Insulin glargine: A new basal insulinLEVIEN, Terri L; BAKER, Danial E; WHITE, John R et al.The Annals of pharmacotherapy. 2002, Vol 36, Num 6, pp 1019-1027, issn 1060-0280Article

Can a New Ultra-Long-Acting Insulin Analogue Improve Patient Care? Investigating the Potential Role of Insulin DegludecROBINSON, Jennifer D; NEUMILLER, Joshua J; CAMPBELL, R. Keith et al.Drugs (Basel). 2012, Vol 72, Num 18, pp 2319-2325, issn 0012-6667, 7 p.Article

Sodium-Glucose Co-Transport Inhibitors: Progress and Therapeutic Potential in Type 2 Diabetes MellitusNEUMILLER, Joshua J; WHITE, John R; CAMPBELL, R. Keith et al.Drugs (Basel). 2010, Vol 70, Num 4, pp 377-385, issn 0012-6667, 9 p.Article

Exenatide : An incretin mimetic for the treatment of type 2 diabetes mellitusILTZ, Jason L; BAKER, Danial E; SETTER, Stephen M et al.Clinical therapeutics. 2006, Vol 28, Num 5, pp 652-665, issn 0149-2918, 14 p.Article

Insulin glargineCAMPBELL, R. Keith; WHITE, John R; LEVIEN, Terri et al.Clinical therapeutics. 2001, Vol 23, Num 12, pp 1938-1957, issn 0149-2918Article

Miglitol : Assessment of its role in the treatment of patients with diabetes mellitusCAMPBELL, Lance K; BAKER, Danial E; CAMPBELL, R. Keith et al.The Annals of pharmacotherapy. 2000, Vol 34, Num 11, pp 1291-1301, issn 1060-0280Article

Phosphodiesterase 5 inhibitors for erectile dysfunctionSETTER, Stephen M; ILTZ, Jason L; FINCHAM, Jack E et al.The Annals of pharmacotherapy. 2005, Vol 39, Num 7-8, pp 1286-1295, issn 1060-0280, 10 p.Article

Insulin aspart : A new rapid-acting insulin analogSETTER, Stephen M; CORBETT, Cynthia F; CAMPBELL, R. Keith et al.The Annals of pharmacotherapy. 2000, Vol 34, Num 12, pp 1423-1431, issn 1060-0280Article